These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 11423477

  • 1. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C, Bailbé D, Meile MJ, Kergoat M, Portha B.
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [Abstract] [Full Text] [Related]

  • 2. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
    Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B.
    Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
    [Abstract] [Full Text] [Related]

  • 3. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG, Pittner R, Jodka C, Smith P, Young A.
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [Abstract] [Full Text] [Related]

  • 4. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.
    J Biol Chem; 2003 Jan 03; 278(1):471-8. PubMed ID: 12409292
    [Abstract] [Full Text] [Related]

  • 5. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY, Kim YS, Ahn IS, Kim DS, Kang S, Hong SM, Park S.
    J Pharmacol Sci; 2009 Dec 03; 111(4):361-71. PubMed ID: 20019445
    [Abstract] [Full Text] [Related]

  • 6. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
    Kaya-Dagistanli F, Ozturk M.
    Acta Histochem; 2013 Jul 03; 115(6):577-86. PubMed ID: 23351716
    [Abstract] [Full Text] [Related]

  • 7. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R, Zhou J, Doyle ME, Egan JM.
    Endocrinology; 2000 Dec 03; 141(12):4600-5. PubMed ID: 11108273
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
    Dachicourt N, Serradas P, Bailbé D, Kergoat M, Doaré L, Portha B.
    J Endocrinol; 1997 Nov 03; 155(2):369-76. PubMed ID: 9415071
    [Abstract] [Full Text] [Related]

  • 9. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.
    J Mol Endocrinol; 2005 Aug 03; 35(1):27-38. PubMed ID: 16087719
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
    Song X, Sun X, Hao H, Han Q, Han W, Mu Y.
    Stem Cells Dev; 2021 May 01; 30(9):502-514. PubMed ID: 33677993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S, Kutluata N, Afşar S, Ozdaş SB, Akkan AG.
    Pharmacology; 2005 Jun 01; 74(3):119-26. PubMed ID: 15746570
    [Abstract] [Full Text] [Related]

  • 15. Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas.
    Gezginci-Oktayoglu S, Bolkent S.
    Biochem Cell Biol; 2009 Aug 01; 87(4):641-51. PubMed ID: 19767827
    [Abstract] [Full Text] [Related]

  • 16. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
    Malendowicz LK, Macchi C, Nussdorfer GG, Nowak KW, Zyterska A, Ziolkowska A.
    Int J Mol Med; 2003 Jun 01; 11(6):763-6. PubMed ID: 12736719
    [Abstract] [Full Text] [Related]

  • 17. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F, Fehmann HC, Göke R, Göke B.
    Diabetes; 1995 Jan 01; 44(1):16-9. PubMed ID: 7813808
    [Abstract] [Full Text] [Related]

  • 18. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
    Sahraoui A, Winzell MS, Gorman T, Smith DM, Skrtic S, Hoeyem M, Abadpour S, Johansson L, Korsgren O, Foss A, Scholz H.
    PLoS One; 2015 Jan 01; 10(3):e0121204. PubMed ID: 25793295
    [Abstract] [Full Text] [Related]

  • 19. Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.
    Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG, Young AA.
    Endocrinology; 2005 Apr 01; 146(4):2069-76. PubMed ID: 15618356
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
    Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R.
    Endocrinology; 2002 Nov 01; 143(11):4397-408. PubMed ID: 12399437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.